LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial activity

	LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial activity
	He, XQ; Zhang, YT; Lou, JC; Wu, JY; Xu, S; Zhu, GD; Tang, JX; Fang, YQ; Cao, J
	2026
发表期刊	PLoS Pathog.
ISSN	1553-7366
卷号	22 期号:3
摘要	Malaria control is challenged by the emergence of resistance to virtually all antimalarial drugs, from the frontline artemisinin to other classes, highlighting the critical need for new therapies. This study demonstrates that the human antimicrobial peptide LL-37 exhibits antiplasmodial activity against both drug-sensitive and drug-resistant parasites in vitro. LL-37 selectively targets infected red blood cells through membrane disruption mediated by phosphatidylserine externalization and cholesterol depletion. Elevated plasma LL-37/CRAMP levels were observed in malaria patients and infected mice, and exogenous LL-37/CRAMP administration reduced parasitemia, improved survival, and modulated pro-inflammatory cytokine levels in a mouse model. CRAMP-deficient mice showed higher susceptibility to infection, underscoring its role in host defense. Our findings reveal a naturally occurring host defense mechanism centered on LL-37/CRAMP, which acts through direct targeting of the infected erythrocyte membrane. However, therapeutic administration after infection establishment showed limited efficacy, likely due to rapid peptide degradation in vivo, and the effective concentrations required for direct killing in vitro are substantially higher than endogenous systemic levels. The reduction in systemic cytokines observed in treated mice is likely primarily attributable to decreased parasite burden rather than direct immunomodulation. Further studies are needed to evaluate stabilized analogs, optimized delivery strategies, and combination approaches before therapeutic applications can be considered.
收录类别	SCIE
语种	英语
文献类型	期刊论文
条目标识符	http://ir.kiz.ac.cn/handle/152453/14826
专题	科研部门_天然药物功能蛋白质学科组（赖仞）
推荐引用方式 GB/T 7714	He, XQ,Zhang, YT,Lou, JC,et al. LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial activity[J]. PLoS Pathog.,2026,22(3).
APA	He, XQ.,Zhang, YT.,Lou, JC.,Wu, JY.,Xu, S.,...&Cao, J.(2026).LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial activity.PLoS Pathog.,22(3).
MLA	He, XQ,et al."LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial activity".PLoS Pathog. 22.3(2026).

条目包含的文件
文件名称/大小	文献类型	版本类型	开放类型	使用许可
2026070604.pdf（1710KB）	期刊论文	出版稿	开放获取	CC BY-NC-SA	请求全文